title: [Aseptic meningitis due to OKT3].
authors.forename: M C
authors.initials: MC
authors.lastname: Uribe Roca
authors.forename: M C
authors.initials: MC
authors.lastname: Zurru
authors.forename: E M
authors.initials: EM
authors.lastname: Gatto
authors.forename: E C
authors.initials: EC
authors.lastname: Maggiora
authors.forename: C
authors.initials: C
authors.lastname: Agost Carreño
authors.forename: M
authors.initials: M
authors.lastname: Luciano
mesh_terms: D000328:Adult; D006084:Graft Rejection / Q000188:drug therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D007275:Injections, Intravenous; D016030:Kidney Transplantation / Q000009:adverse effects; D008297:Male; D008582:Meningitis, Aseptic / Q000139:chemically induced*; D016853:Muromonab-CD3 / Q000009:adverse effects*
chemical_list: D007166:Immunosuppressive Agents; D016853:Muromonab-CD3
vernacular_title: Meningitis aséptica por OKT3.